Sanjay Verma of Akums Drugs & Pharmaceuticals, Manu Gupta of Cadila Pharmaceuticals, Rahul Borse of RPG Life Sciences, Krishna Sai T of Biocon and Amit Saluja of NASSCOM are speakers
Indian Pharma Post, an online platform that provides news and insights on the Pharmaceutical industry, is organising an E-conference on "Role of Digitalization in Pharma Sector" on 24th June, 2022.
One can register for the E-conference as a delegate by clicking on the link https://us06web.zoom.us/webinar/register/WN_bhKWa6ZmSPCRy8gRhXNsmw .
The speakers for the E-conference are: Sanjay Verma, Group CIO & Vice President - IT, Akums Drugs & Pharmaceuticals Limited, Manu Gupta, Vice President - IT, Cadila Pharmaceuticals Limited; Rahul Borse, Head - IT, RPG Life Sciences Limited; Krishna Sai T, Associate Vice President - IT & SAP, Biocon Limited; Amit Saluja, Senior Director and Center Head, NASSCOM; and Pravin Prashant, Editor, Indian Pharma Post.
COVID-19 has accelerated the pace of digitalization across industries including the pharmaceutical sector and the industry is now recognizing digital technology adoption and innovation as an essential item to drive growth.
The Indian pharmaceutical sector is ranked third largest by volume in the global market and is currently valued at US $41.7 billion and it is forecast to reach US $65 billion by 2024 and US $120 billion by 2030. Digital technologies like Artificial Intelligence (AI), Machine Learning (ML), 3D Printing, and Additive Manufacturing are helping Indian pharmaceutical companies to step up R&D process, conducting tests in less time, improving efficiencies and compliances in manufacturing, and increasing profitability.
The growing affordability of exponential technologies such as those that enable AI is bringing cost-prohibitive tools to the mass market, reducing production costs and enabling the creation of more individualized products and services. Given the disruptive nature of these technologies, it will prove increasingly important for pharmaceutical manufacturing chains to be operationally agile.
Informatics solutions that offer the versatility and scalability to extend capabilities as business needs change will give pharmaceutical manufacturers the best competitive advantage.
According to ISPE (International Society of Pharmaceutical Engineering), digitalization, an important component of Pharma 4.0, will connect everything, creating new levels of transparency and adaptivity for a digitalized plant floor. This will enable faster decision making, and provide in-line and in-time control over the business, operations, and quality. It will also require higher levels of security since connected systems heighten vulnerability.
The key discussion points for the "Role of Digitalization in Pharma Sector" are: Where do Indian pharmaceutical companies stand in terms of digitalization?; Effective use of digital technologies by Indian pharmaceutical companies; Does the Indian pharma industry need partnerships for the next stage of digital transformation?; Technology investments required to achieve Pharma 4.0; Developing skilled manpower to implement Pharma 4.0 in an integrated manner; and achieving sustainability through digitalization.
Pfizer’s phase 3 studies of novel antibiotic combination offer new hope for patients with multidrug-resistant infections and treatment options
Merck partners with California-based research group to study catalysis innovation through machine learning
Philips and Masimo introduce advanced monitoring capabilities to Philips high acuity patient monitors
Subscribe To Our Newsletter & Stay Updated